Community Research and Development Information Service - CORDIS

Characterizing the clinical relevance and the mechanism underlying TRIB2-mediated drug resistance to MEK inhibitiors in the context of melanoma

From 2018-03-05 to 2020-03-04, Grant Agreement signed

Project details

Total cost:

EUR 160 635,60

EU contribution:

EUR 160 635,60

Coordinated in:

Portugal

Call for proposal:

H2020-MSCA-IF-2016See other projects for this call

Funding scheme:

MSCA-IF-EF-RI - RI – Reintegration panel

Objective

Coordinator

UNIVERSIDADE DO ALGARVE
Portugal

EU contribution: EUR 160 635,60


CAMPUS DE PENHA
8005 139 FARO
Portugal
Activity type: Higher or Secondary Education Establishments
Record Number: 208947 / Last updated on: 2017-03-07
Follow us on: RSS Facebook Twitter YouTube Managed by the EU Publications Office Top